Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.
G
140%
5-year Growth Rate
R
3/6
5-year Risk Analysis
O
13,01%
Outlook 12/26
W
85,73%
Margin of safety
T
45,83%
Analyst Price Target
H
DOWN
50-week EMA Trend
Company Info
EPS Growth 5Y
29,31%
Revenue growth 5Y
185,78%
Price growth 5Y
244,47%
Market Cap
$4,96 B
Long-Term Debt
$0,59 B
Annual earnings
N/A
Dividend
$0,00
Dividend Yield
0,00%
Industry
Country
Website
ISIN Number
Telix Pharmaceuticals Price Chart
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
$21,35
45.83%
Last Update: 04/11/2026
Analysts: 12
Highest Price Target $32,00
Average Price Target $21,35
Lowest Price Target $18,00
Top growth stocks in the health care sector
| Stock | Rate of Return 5Y | Price 5Y | Div. 5Y | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|---|---|
|
Telix Pharmaceuticals
ASX:TLX
|
244,47% | 244,47% | 0,00% | 140,36% | 3/6 | 13,01% | 85,73% | 45,83% | DOWN |
